MedPath

Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement

Not Applicable
Completed
Conditions
Surgical Valve Replacement
Transcatheter Valve Replacement
Cardiovascular Disease
Valve Surgery
Aortic Valve Stenosis
Cognitive Assessments
Interventions
Other: Observational/Cognitive Assessment
Registration Number
NCT02971020
Lead Sponsor
Minnesota Veterans Medical Research and Education Foundation
Brief Summary

The investigators are conducting a pilot study to compare cognitive outcomes among Veterans with severe aortic valve stenosis who are scheduled to undergo either aortic valve replacement.

Detailed Description

The investigators are conducting a pilot study to compare cognitive outcomes in up to 60 Veterans with severe aortic valve stenosis who are scheduled to undergo either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) at the Minneapolis VA Health Care System. Participants will be administered a short battery of cognitive tests before and three months after TAVR or SAVR over/up to a two year study period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Severe aortic stenosis (AVA: 1 cm2 and/or mean gradient =or > 40 mmHg and/or peak velocity > 4 m/s)
  • Scheduled to undergo either surgical or transcatheter aortic valve replacement at the Minneapolis VA Health Care System
Exclusion Criteria
  • Severe cognitive impairment at baseline (i.e. unable to understand or follow-up study procedures)
  • Unable or unwilling to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Surgical Aortic Valve ReplacementObservational/Cognitive AssessmentMontreal Cognitive Assessment (MoCA); Trail Making Test Part A; Trail Making Test Part B; Phonemic Fluency (letter fluency) and Semantic Fluency (category).
Transcatheter Aortic Valve ReplacementObservational/Cognitive AssessmentMontreal Cognitive Assessment (MoCA); Trail Making Test Part A; Trail Making Test Part B; Phonemic Fluency (letter fluency) and Semantic Fluency (category).
Primary Outcome Measures
NameTimeMethod
Montreal Cognitive AssessmentThree Months

Estimate the means and standard deviations of changes in selected cognitive measures between baseline (pre-TAVR or pre-SAVR) and 3 months post-TAVR or post-SAVR, identify baseline correlates of those changes, and characterize baseline cognitive function and cognitive history of patients who undergo TAVR or SAVR.

Trail Making3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Minneapolis VA Health Care System

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath